Member Info for TrumptonTown

Think the news hasn't really got out yet.. exciting times

I'm calm here if fact it's exciting times Booby... Seems your pleasure is trolling a BB - LOL!!

Rattled! LOL!!

Poor him.. won't be getting his deramping vouchers this week. He did predict 0.2 LOL!!

We'll see ;-)

https://sciencebusiness.net/news/pharma-industry-launches-1-billion-initiative-find-new-antibiotics

The current market failure has led the antibiotic pipeline to “the verge of collapse,” said David Ricks, CEO of US pharma Eli Lilly, who is president of the pharmaceutical industry body IFPMA. “The AMR Action Fund will support innovative antibiotic candidates through the most challenging later stages of drug development, ultimately providing governments time to make the necessary policy reforms to enable a sustainable antibiotic pipeline,” Dicks said.

BOOM!! https://www.nytimes.com/2020/07/09/health/antibiotics-pharma-drug-resistance.html

Check out this quote from Booby earlier this week - LOL! He's not getting his deramping vouchers this week! LOL!!!

" Look at the SP, anyone think this will hit 0.2 by the end of the week........ "

https://www.ifpma.org/resource-centre/new-amr-action-fund-steps-in-to-save-collapsing-antibiotic-pipeline/

Hope for Iclaprim? https://www.businesswire.com/news/home/20200709005154/en/%C2%A0New-AMR-Action-Fund-steps-save-collapsing

This didnt happen overnight.. did the new BoD know???https://www.fightinfectiousdisease.org/post/press-release-partnership-to-fight-infectious-disease-applauds-global-effort-to-help-address-amr

Take a look at AMRActionFund (@AMRActionFund): https://twitter.com/AMRActionFund?s=09

https://youtu.be/71o63MK0abA
There's definitely interested in new antibiotics . Iclaprim is at Phase III

Excellent article

I've reported him numerous times to LSE - I know he's had at least one ban for libelous comments.

Seems nobody knows what has happened to this.. There must have been some outcome/work done ?
https://www.lse.co.uk/rns/MTFB/us-army-funded-project-to-evaluate-iclaprim-8h2jqdd83jg8ujl.html

Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with 'iclaprim', to improve safety and efficacy administered by a novel enhanced aerosol technology

From TILS LSE - Considering Tiziana themselves were listen in 2013 via a cash shell (Alexander David Investments plc) then I think a listing via a RTO is likely. I do however think that it will be Bould Opportunities that are used as the vehicle to list Accustem...

The share a similar registered office (Cheapside London)

Bould CEO Syms has previous experience with spin outs

Syms completed a PhD in Cancer Research at Cardiff University.. Tiziana was founded originally by a group of 3 scientists at that same University... Cerrone was part funder of the original study..

Syms was a speaker at BioMotif in Cardiff in 2013 (about the same time Tiziana was founded)

Can you screen shot???

Booby - Lol YOU'RE not allowed to say anything positive about Motif. Mind you don't overstep the mark again and get a ban.

Doyezee - ?? Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with 'iclaprim', to improve safety and efficacy administered by a novel enhanced aerosol technology